Vascepa is a h__l of a lot cheaper too. I've posted my results and correlations with V dosage(limited V side effects compared to Repatha, et al) to educate the folks on the Amgn, lly and Espr boards. We have seen a lot of DTC ads from those folks on TV lately...and wonder if that is a last ditch effort to compete with the likes of V and/or avoid the loss of market share even from off-label V use.
News 
Market Data 
Discover 
AI
